Litcius/Paper detail

PD1+TIGIT+2B4+KLRG1+ Cells Might Underlie T Cell Dysfunction in Patients Treated with BCMA-Directed Chimeric Antigen Receptor T Cell Therapy

A. Mishra, Timothy M. Schmidt, Ella B. Martell, Alex S. Chen, Reyna Elvan Dogru, Peiman Hematti, Natalie S. Callander

2023Transplantation and Cellular Therapy13 citationsDOI

Topics & Concepts

TIGITChimeric antigen receptorCell therapyReceptorMedicineAntigenImmunologyCellT cellCancer researchChemistryInternal medicineImmune systemCD8BiochemistryCAR-T cell therapy research
PD1+TIGIT+2B4+KLRG1+ Cells Might Underlie T Cell Dysfunction in Patients Treated with BCMA-Directed Chimeric Antigen Receptor T Cell Therapy | Litcius